Optinose, INC Form 4 insider transactions

OptiNose CEO Ramy Mahmoud reports acquisition and disposal of common stock related to vesting of performance-based restricted stock units and subsequent sale to cover tax obligations.

Director John Fletcher acquired 85,000 stock options in OptiNose, Inc. on June 6, 2024.

Director Sandra L. Helton acquired 75,000 stock options in OptiNose, Inc. on June 6, 2024.

Director Wilhelm Groenhuyzen acquired 75,000 stock options in OptiNose, Inc. on June 6, 2024.

Director Kyle Dempsey of OptiNose, Inc. reports the acquisition of 75,000 stock options with an exercise price of $1.04.

Director Heyman Tomas J. acquired 75,000 stock options in OptiNose, Inc. on June 6, 2024, according to a Form 4 filing.

Director Eric Bednarski of OptiNose, Inc. was granted stock options to purchase 75,000 shares of common stock.

Director Catherine E. Owen acquired 75,000 stock options in OptiNose, Inc. on June 6, 2024.

Anthony J. Krick, Chief Accounting Officer of OptiNose, Inc., sold shares to cover tax withholding obligations related to vesting restricted share units.

Michael F. Marino III, Chief Legal Officer & Corp Sec of OptiNose, Inc., reports acquisition and disposition of company stock related to vesting of restricted stock units and tax obligations.

OptiNose CEO Ramy Mahmoud reports acquisition of shares through vesting of restricted stock units and subsequent sale to cover tax obligations.

Chief Accounting Officer Anthony J. Krick received restricted stock units and stock options from OptiNose, Inc. on February 28, 2024.

Paul Spence Jr., Chief Commercial Officer of OptiNose, Inc., was granted stock options and restricted stock units (RSUs) on February 28, 2024.

Michael F. Marino III, Chief Legal Officer & Corp Sec of OptiNose, Inc., reports the acquisition of stock options and restricted stock units.

OptiNose CEO Ramy Mahmoud reports acquisition of shares and stock options, including restricted stock units (RSUs) and stock options vesting over four years.